Gynecologic Oncology Group: Uterine Cervical Neoplasms trials

The registry lists 38 Uterine Cervical Neoplasms studies with Gynecologic Oncology Group as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 6Phase 2 18Phase 3 6No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT01267253Phase 2Results posted
• Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00691301Phase 2Results posted
• Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial CancerTerminatedNCT00577317Phase 3Results posted
• Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00101192Phase 2Results posted
• Topotecan in Treating Women With Persistent or Recurrent Cervical CancerCompletedNCT00087126Phase 2Results posted
• Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical CancerTerminatedNCT00070317Not applicableResults posted
• Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the CervixCompletedNCT00003377Phase 1Results posted
• Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical CancerStatus unknownNCT01295502Phase 1
• Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical CancerCompletedNCT01098630
• Studying Biomarkers in Blood Samples From Patients With Invasive Cervical CancerStatus unknownNCT01074424
• Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar CancerStatus unknownNCT00956670Not applicable
• Study of Pap Smears From Patients Enrolled on Clinical Trial GOG-171Status unknownNCT00898144
• Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
• Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph NodesCompletedNCT00460356
• Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00276796Phase 2
• Pelvic Exenteration in Treating Patients With Recurrent Cervical CancerCompletedNCT00217633Phase 2
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerCompletedNCT00104910Phase 1
• Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the CervixCompletedNCT00087113Phase 2
• Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical CancerCompletedNCT00068549Phase 1
• Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical CancerCompletedNCT00054444Phase 1
• Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the CervixTerminatedNCT00054067Phase 3
• Vaginal Changes and Sexual Function in Patients With Cervical CancerCompletedNCT00053261
• EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical CancerCompletedNCT00049231Not applicable
• Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the CervixTerminatedNCT00030472Phase 2
• SU5416 in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00026260Phase 2
• Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and AnemiaCompletedNCT00017004Phase 3
• Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00016926Phase 2
• Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the CervixTerminatedNCT00006482Phase 2
• Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the CervixTerminatedNCT00006224Phase 2
• Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical CancerCompletedNCT00005837Phase 2
• Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical CancerCompletedNCT00003945Phase 3
• Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial CancerTerminatedNCT00003624Phase 2
• Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical CancerCompletedNCT00003379Phase 1/2
• Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the CervixCompletedNCT00003078Phase 3
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical CancerCompletedNCT00002813Phase 2
• Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal CancerCompletedNCT00002562Phase 2
• Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical CancerCompletedNCT00002536Phase 3
• Etoposide in Treating Patients With Advanced Ovarian or Cervical CancerTerminatedNCT00002478Phase 2